R&D Pharma investment for 10% acquisition (Belgravia Capital, Belgravia, or the Company) is pleased to announce that it has acquired 10.03% of the outstanding common shares of R&D Pharma Corp. (RDP). RDP is a Canadian corporation developing a vertically integrated medicinal cannabis business in Jamaica. Belgravia has acquired four million (4 million) common shares of RDP at a price of twenty-five (25) cents per share. Belgravia has the right to appoint an independent director to the Board of RDP. Mr. Kevin Strong, the Chief Financial Officer (CFO) of Belgravia, has been appointed CFO of RDP. The funding of the acquisition was by way of Canadian $500,000 (five- hundred thousand dollars) and 5,000,000 (five million) common shares of Belgravia. RDP, through one of its subsidiaries, holds a Tier 3 Cultivators Licence in Jamaica. This licence is one of only three Cultivators licences awarded by the Cannabis Licensing Authority (CLA). The CLA is an agency of the Ministry of Industry, Commerce, Agriculture and Fisheries of Jamaica that was established in 2015 with the mandate of creating and regulating Jamaicas legal Cannabis and hemp industry. In addition to being a holder of the Tier 3 Cultivators Licence, RDP also has been awarded conditional processing, herb house, spa and dispensary licences. Jamaica is known to have a world-renowned medical cannabis community with recognized landrace plants in their natural environment. A Cannabis landrace is a plant grown in its natural environment and developed through traditional agricultural practices. This results in superior products that are internationally desired by markets. The consistent flowering light cycles of Jamaica, constant air flow, and other advantageous agronomic and economic conditions of the island, allows RDP to be an internationally low cost efficient producer of plants and medicinal products, for use in both the domestic and medical tourism industry, and for international export. Mr. Mehdi Azodi, President and Chief Executive Officer of Belgravia stated: We are excited to have completed our acquisition of 10% of RDP. Under the leadership of its Executive Chairman, Yohan Chin, President, Richard Bailey, and Chief Executive Officer, Derrick Lewis, RDP is one of only of only three companies to have been awarded a Tier 3 Cultivators Licence by the Government of Jamaica. This is a testament to the quality of the management team. The Tier 3 licence allows for the cultivation of over five acres of land with plants for medical, scientific, and therapeutic purposes.